These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 568479)
21. Prevalence of lupus anticoagulant in multiparous women in Benin City, Nigeria. Awodu OA; Ejele OA; Shokunbi WA; Enosolease ME Niger Postgrad Med J; 2003 Mar; 10(1):19-22. PubMed ID: 12812147 [TBL] [Abstract][Full Text] [Related]
22. [Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities]. Raleigh-Rosendo R; Diez-Ewald M; Vizcaíno G; Fereira H; Arteaga-Vizcaíno M; Arreaza M Invest Clin; 1990; 31(1):45-55. PubMed ID: 2128614 [TBL] [Abstract][Full Text] [Related]
29. Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants. Regnault V; Béguin S; Wahl D; de Maistre E; Coenraad Hemker H; Lecompte T Thromb Haemost; 2003 Feb; 89(2):208-12. PubMed ID: 12574797 [TBL] [Abstract][Full Text] [Related]
30. Circulating anticoagulant against factor XI and thrombocytopenia with platelet aggregation inhibition in systemic lupus erythematosus. Leone G; Accorra F; Boni P Acta Haematol; 1977; 58(4):240-5. PubMed ID: 410226 [TBL] [Abstract][Full Text] [Related]
31. Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients. Regan MG; Lackner H; Karpatkin S Ann Intern Med; 1974 Oct; 81(4):462-8. PubMed ID: 4213298 [No Abstract] [Full Text] [Related]
32. The increased percentage of megathrombocytes in various clinical disorders. Garg SK; Lackner H; Karpatkin S Ann Intern Med; 1972 Sep; 77(3):361-9. PubMed ID: 5066195 [No Abstract] [Full Text] [Related]
33. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus. McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518 [TBL] [Abstract][Full Text] [Related]
34. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus. Yin ET; Gaston LW Thromb Diath Haemorrh; 1965 Sep; 14(1-2):88-115. PubMed ID: 16955969 [TBL] [Abstract][Full Text] [Related]
35. Lupus anticoagulant in Nigerian women with preeclampsia. Awodu OA; Shokunbi WA; Ejele OA West Afr J Med; 2003 Sep; 22(3):240-2. PubMed ID: 14696949 [TBL] [Abstract][Full Text] [Related]
36. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications. Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474 [TBL] [Abstract][Full Text] [Related]
38. Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis. Sanfelippo MJ; Drayna CJ Am J Clin Pathol; 1982 Mar; 77(3):275-9. PubMed ID: 6803570 [TBL] [Abstract][Full Text] [Related]
39. Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients. Watson KV; Schorer AE Am J Med; 1991 Jan; 90(1):47-53. PubMed ID: 1898838 [TBL] [Abstract][Full Text] [Related]
40. Antiplatelet antibody determination using platelet factor 3 assay in thrombocytopenic patients. Chong LL Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Nov; 19(4):233-7. PubMed ID: 3816366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]